title: Dynamics of Cytosine Methylation in the Proximal Promoters of CYP3A4 and CYP3A7 in Pediatric and Prenatal Livers.
abstract: Members of the human CYP3A family of metabolizing enzymes exhibit developmental changes in expression whereby CYP3A7 is expressed in fetal tissues, followed by a transition to expression of CYP3A4 in the first months of life. Despite knowledge about the general pattern of CYP3A activity in human development, the mechanisms that regulate developmental expression remain poorly understood. Epigenetic changes, including cytosine methylation, have been suggested to play a role in the regulation of CYP3A expression. The objective of this study was to investigate changes in cytosine methylation of the CYP3A4 and CYP3A7 genes in human pediatric and prenatal livers. The methylation status of cytosine-phospho-guanine dinucleotides was determined in 16 pediatric liver samples using methyl-seq and confirmed by bisulfite sequencing of 48 pediatric and 34 prenatal liver samples. Samples were separated by age into five groups (prenatal, < 1 year of age, 1.8-6 years, 7-11 years, and 12-17 years). Methyl-seq anaylsis revealed that cytosines in the proximal promoter of CYP3A7 are hypomethylated in neonates compared with adolescents (P < 0.001). In contrast, a cytosine 383 base pair upstream of CYP3A4 is hypermethylated in liver samples from neonates compared with adolescents (P = 0.00001). Developmental changes in methylation of cytosines in the proximal promoters of CYP3A4 and CYP3A7 in pediatric livers were confirmed by bisulfite sequencing. In addition, the methylation status of cytosine in the CYP3A4 and CYP3A7 proximal promoters correlated with changes in developmental expression of mRNA for the two enzymes.
authors.affiliation: Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation (C.A.V., C.B., J.S.L.), and Division of Experimental and Translational Genetics (S.Q.Y.), Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri cvyhlidal@cmh.edu.
authors.forename: Carrie A
authors.initials: CA
authors.lastname: Vyhlidal
authors.affiliation: Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation (C.A.V., C.B., J.S.L.), and Division of Experimental and Translational Genetics (S.Q.Y.), Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri.
authors.forename: Chengpeng
authors.initials: C
authors.lastname: Bi
authors.affiliation: Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation (C.A.V., C.B., J.S.L.), and Division of Experimental and Translational Genetics (S.Q.Y.), Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri.
authors.forename: Shui Qing
authors.initials: SQ
authors.lastname: Ye
authors.affiliation: Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation (C.A.V., C.B., J.S.L.), and Division of Experimental and Translational Genetics (S.Q.Y.), Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri.
authors.forename: J Steven
authors.initials: JS
authors.lastname: Leeder
mesh_terms: D000293:Adolescent; D000367:Age Factors; D000375:Aging / Q000235:genetics* / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D051544:Cytochrome P-450 CYP3A / Q000235:genetics* / Q000378:metabolism; D003596:Cytosine; D019175:DNA Methylation; D044127:Epigenesis, Genetic; D005260:Female; D018507:Gene Expression Regulation, Developmental; D015971:Gene Expression Regulation, Enzymologic; D005865:Gestational Age; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008099:Liver / Q000201:enzymology*; D008297:Male; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism
chemical_list: D012333:RNA, Messenger; D003596:Cytosine; C103123:CYP3A7 protein, human; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human